Google Ai Pharma News

Salt Lake City-based Recursion Pharmaceuticals is revolutionizing the field of drug discovery by harnessing the power of artificial intelligence (AI). Using AI-powered models, Recursion Pharmaceuticals can identify new experimental drug candidates with great accuracy and efficiency. Despite the struggles faced by the healthcare sector in the stock market this year, small stocks that incorporate AI…

The traditional model of reaching doctors in pharmaceutical marketing is undergoing a significant change due to the evolution of data in recent years. The old model followed a predefined decision tree, where initial contact was made followed by a sales rep visit, then a care center follow-up, and so on. However, advancements in technology such…

Just a moment... …

Collaboration aims to help pharmaceuticals drive efficiencies and business value. In association with Amazon Web Services (AWS), Eversana revealed plans to fast-track the use of artificial intelligence (AI) in the life sciences sector. Through this association, the organizations plan on implementing the technology to help pharmaceutical and life science manufacturers drive efficiencies and business…

Artificial intelligence (AI) and machine learning (ML) have become widely used in various industries, including the pharmaceutical industry. These technologies are already making an impact on drug development and manufacturing. However, they also raise unique regulatory challenges that need to be addressed. For instance, if a ML algorithm can autonomously modify a manufacturing process to…

The EMA has outlined issues that come hand-in-hand with the advantages artificial intelligence and machine learning bring to the medicine making process. Credit: Shutterstock/volodyar. …

PAUL HUDSON, boss of Sanofi, is brandishing an iPhone. He is keen to show off the French drugmaker’s new artificial-intelligence (AI) app, plai. It draws on more than 1bn data points to provide “snackable” information, from warnings about low stocks of a drug to questions for a meeting with an ad agency or suggestions to…

F ive years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will offer a new kind of treatment plan that involves both pharmaceutical-based medication and a prescription digital therapeutic. Accessible through the patient’s smartphone,…

In the aftermath of the Covid-19 pandemic, a new surge in artificial intelligence (AI) technology is beginning to jolt the pharma industry once again. At the Outsourcing in Clinical Trials East Coast conference, the message was clear: trial sponsors and service providers must embrace the change, or risk becoming obsolete. During a provocative keynote address,…

Press play to listen to this article Voiced by artificial intelligence. The next blockbuster drug could be invented by artificial intelligence. For years, billions of dollars have been poured into bringing AI into the drug development process. Finally, it seems the cash might be paying off.  Medicines designed by AI for conditions including lymph cancers,…